Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Ischemic Heart Disease

  Free Subscription


Articles published in Blood

Retrieve available abstracts of 7 articles:
HTML format



Single Articles


    November 2019
  1. AHN IE
    Cardiovascular adverse events of ibrutinib.
    Blood. 2019;134:1881-1882.
    PubMed    


    October 2019
  2. DICKERSON T, Wiczer T, Waller A, Philippon J, et al
    Hypertension and Incident Cardiovascular Events Following Ibrutinib Initiation.
    Blood. 2019 Oct 3. pii: blood.2019000840. doi: 10.1182/blood.2019000840.
    PubMed     Abstract available


    February 2019
  3. DE VRIES PS, Sabater-Lleal M, Huffman JE, Marten J, et al
    A genome-wide association study identifies new loci for factor VII and implicates factor VII in ischemic stroke etiology.
    Blood. 2019;133:967-977.
    PubMed     Abstract available


  4. NAVI BB, Reiner AS, Kamel H, Iadecola C, et al
    Arterial thromboembolic events preceding the diagnosis of cancer in older persons.
    Blood. 2019;133:781-789.
    PubMed     Abstract available


    January 2019
  5. LATIFI Y, Moccetti F, Wu M, Xie A, et al
    Thrombotic microangipathy as a cause for cardiovascular toxicity from the BCR-ABL1 tyrosine kinase inhibitor ponatinib.
    Blood. 2019 Jan 28. pii: blood-2018-10-881557. doi: 10.1182/blood-2018-10-881557
    PubMed     Abstract available


    October 2018
  6. SCHNEPPENHEIM R, Hellermann N, Brehm MA, Klemm U, et al
    The von Willebrand factor Tyr2561 allele is a gain-of-function variant and a risk factor for early myocardial infarction.
    Blood. 2018 Oct 26. pii: blood-2018-04-843425. doi: 10.1182/blood-2018-04-843425
    PubMed     Abstract available


    December 2017
  7. NAZIR S, Gadi I, Al-Dabet MM, Elwakiel A, et al
    Cytoprotective activated protein C averts Nlrp3 inflammasome-induced ischemia-reperfusion injury via mTORC1 inhibition.
    Blood. 2017;130:2664-2677.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: